Tudor Mocan

Croitorilor St. 19-21
Cluj-napoca, CJ 400012, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

CRAFITY and PALBI Define a Machine Learning-Supported Prognostic Framework in Hepatocellular Carcinoma-Data from an Eastern European Cohort with Low Macrotrabecular-Massive Prevalence.

CRAFITY and PALBI Define a Machine Learning-Supported Prognostic Framework in Hepatocellular Carcinoma-Data from an Eastern European Cohort with Low Macrotrabecular-Massive Prevalence.

Journal: Diseases (Basel, Switzerland)

Published: June 08, 2026

AI-guided additive scoring model for differential diagnosis of primary liver cancer.

AI-guided additive scoring model for differential diagnosis of primary liver cancer.

Journal: JHEP reports : innovation in hepatology

Published: October 23, 2025

Comparative Outcomes of Pancreaticogastrostomy and Pancreaticojejunostomy Following Pancreaticoduodenectomy: A Retrospective Cohort Study from a Romanian High-Volume Center.

Comparative Outcomes of Pancreaticogastrostomy and Pancreaticojejunostomy Following Pancreaticoduodenectomy: A Retrospective Cohort Study from a Romanian High-Volume Center.

Journal: Medicina (Kaunas, Lithuania)

Published: October 15, 2025

A Systematic Review and Meta-Analysis of Preoperative Biliary Drainage Methods in Periampullary Tumors.

A Systematic Review and Meta-Analysis of Preoperative Biliary Drainage Methods in Periampullary Tumors.

Journal: Journal of clinical medicine

Published: August 28, 2025

Turning the Tide-Artificial Intelligence in the Evolving Landscape of Liver Cancer.

Turning the Tide-Artificial Intelligence in the Evolving Landscape of Liver Cancer.

Journal: Cancers

Published: August 06, 2025

Biliary Drainage for the Preoperative Management of Periampullary Neoplasms: A Retrospective Cohort Study.

Biliary Drainage for the Preoperative Management of Periampullary Neoplasms: A Retrospective Cohort Study.

Journal: Medicina (Kaunas, Lithuania)

Published: July 17, 2025

What we missed then, AI sees now: Revisiting legacy large extracellular vesicle data to reveal synergistic biomarkers for liver cancer screening.

What we missed then, AI sees now: Revisiting legacy large extracellular vesicle data to reveal synergistic biomarkers for liver cancer screening.

Journal: JHEP reports : innovation in hepatology

Published: April 11, 2025

The Bleeding Edge: Managing Coagulation and Bleeding Risk in Patients with Cirrhosis Undergoing Interventional Procedures.

The Bleeding Edge: Managing Coagulation and Bleeding Risk in Patients with Cirrhosis Undergoing Interventional Procedures.

Journal: Diagnostics (Basel, Switzerland)

Published: October 28, 2024

Cirrhosis Progression Is Not Associated with Clinically Significant Alterations in Global Hemostasis Assessed by Thromboelastography.

Cirrhosis Progression Is Not Associated with Clinically Significant Alterations in Global Hemostasis Assessed by Thromboelastography.

Journal: Journal of clinical medicine

Published: September 03, 2024

Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration.

Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration.

Journal: Frontiers in pharmacology

Published: May 30, 2024

Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease.

Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease.

Journal: Annals of surgical oncology

Published: March 14, 2024

Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.

Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.

Journal: Hepatology communications

Published: October 17, 2023

Showing 1-12 of 49

Last Updated: 09/26/2026